This is an old revision of this page, as edited by Beetstra (talk | contribs) at 10:58, 20 February 2012 (Saving copy of the {{drugbox}} taken from revid 474722803 of page Tocilizumab for the Chem/Drugbox validation project (updated: 'ChEMBL', 'CAS_number').). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 10:58, 20 February 2012 by Beetstra (talk | contribs) (Saving copy of the {{drugbox}} taken from revid 474722803 of page Tocilizumab for the Chem/Drugbox validation project (updated: 'ChEMBL', 'CAS_number').)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) | This page contains a copy of the infobox ({{drugbox}}) taken from revid 474722803 of page Tocilizumab with values updated to verified values. |
| Monoclonal antibody | |
|---|---|
| Type | Whole antibody |
| Source | Humanized (from mouse) |
| Target | IL-6 receptor |
| Clinical data | |
| Trade names | Actemra, RoActemra |
| AHFS/Drugs.com | Monograph |
| MedlinePlus | a611004 |
| License data |
|
| Routes of administration | Intravenous infusion |
| ATC code | |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Elimination half-life | 8–14 days during steady state (dependent on concentration) |
| Identifiers | |
| ChemSpider | |
| UNII | |
| KEGG | |
| Chemical and physical data | |
| Formula | C6428H9976N1720O2018S42 |
| Molar mass | 145.0 kDa g·mol |
| (what is this?) (verify) | |
